Non-pharmacologic (physiologic) neuroprotection in the treatment of brain ischemia

Annals of the New York Academy of Sciences

Volumn 939, Issue , 2001, Pages 271-282

  Auer, Roland N ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Physiologic neuroprotection; Treatment of brain ischemia

Indexed keywords

GLUCOSE; INSULIN; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OXYGEN;

ANEURYSM; ARTERIAL OXYGEN TENSION; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN VASOSPASM; COLLATERAL CIRCULATION; CONFERENCE PAPER; HEMIPARESIS; HUMAN; HYPOTHERMIA; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; STROKE; VASOCONSTRICTION;

EID: 0034939144     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2001.tb03635.x     Document Type: Conference Paper

References (92)

1. Slowdown in the decline of stroke mortality in the United States, 1978-1986
2. Marked increase of stroke incidence in men between 1972 and 1990 in Frederiksberg, Denmark
3. Long survival after cardiac arrest: Case report and neuropathological findings
4. The declining incidence of stroke
5. Silent infarction in acute stroke patients. Prevalence, localization, risk factors, and clinical significance: The Copenhagen Stroke Study
6. Silent stroke and carotid stenosis
7. Costs of stroke in Sweden. A national perspective
8. The problem of assessing effective neuroprotection in experimental cerebral ischemia
9. Why do all drugs work in animals but none in stroke patients? 2. Neuroprotective therapy
10. Why do all drugs work in animals but none in stroke patients? 1. Drugs promoting cerebral blood flow
11. Dextrose containing intravenous fluid impairs outcome and increases death after eight minutes of cardiac arrest and resuscitation in dogs
12. Cerebral resuscitation after cardiac arrest using hetastarch hemodilution, hyperbaric oxygenation and magnesium ion
13. MK-801 in primate focal ischemia
14. The relationship of structural ischemic brain damage to neurobehavioural deficit: The effect of postischemic MK-801
15. Stroke assessment: Morphometric infarct size versus neurologic deficit
16. The density and distribution of ischemic brain injury in the rat after 2-10 minutes of forebrain ischemia
17. A new model of bilateral hemispheric ischemia in the unanesthetized rat
18. Effects of ischemia and other procedures off the brain and retina of the gerbil (Meriones unguiculatus)
19. Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion
20. Reversible middle cerebral artery occlusion without craniectomy in rats
21. Methods for inducing hypothermia and rewarming
22. General hypothermia for experimental intracardiac surgery
23. Small differences in intraischemic brain temperature critically determine the extent of ischemic neuronal injury
24. Effects of intraischemic hypothermia on cerebral damage in a model of reversible focal ischemia
25. The effect of hypothermia on transient focal ischemia in rat brain evaluated by diffusion- and perfusion-weighted NMR imaging
26. Mild intraischemic hypothermia reduces postischemic hyperperfusion, delayed postischemic hypoperfusion, blood-brain barrier disruption, brain edema, and neuronal damage volume after temporary focal cerebral ischemia in rats
27. Postischemic moderate hypothermia inhibits CA1 hippocampal ischemic neuronal injury
28. Delayed and prolonged post-ischemic hypothermia is neuroprotective in the gerbil
29. Delayed postischemic hypothermia: A six month survival study using behavioral and histologic assessments of neuroprotection
30. Effects of hypothermic metabolic suppression on hippocampal glutamate concentrations after transient global cerebral ischemia
31. Mild hypothermia reduces penumbral glutamate levels in the rat permanent focal cerebral ischemia model
32. Hypothermia prevents ischemia-induced increases in hippocampal glycine concentrations in rabbits
33. Hypothermia: Depression of tricarboxylic acid cycle flux and evidence for pentose phosphate shunt upregulation
34. Effects of hypothermia on evoked potentials, magnetic resonance imaging, and blood flow in focal ischemia in rabbits
35. The significance of brain temperature in focal cerebral ischemia: Histopathological consequences of middle cerebral artery occlusion in the rat
36. Effects of temperature on cerebral tissue oxygen tension, carbon dioxide tension, and pH during transient global ischemia in rabbits
37. 1H spectroscopic imaging
38. Reduction by delayed hypothermia of cerebral infarction following middle cerebral artery occlusion in the rat: A time-course study
39. Delayed induction of mild hypothermia to reduce infarct volume after temporary middle cerebral artery occlusion in rats
40. Spontaneous cerebral hypothermia diminishes focal infarction in rat brain
41. The healing blade: A tale of neurosurgery
42. Mechanism of ventricular fibrillation in hypothermia
43. Experimental cerebral ischemia in Mongolian gerbils. I. Light microscopic observations
44. Delayed neuronal death in the gerbil hippocampus following ischemia
45. Selective vulnerability in the gerbil hippocampus following transient ischemia
46. Treatable ischemic neuronal damage in the gerbil hippocampus
47. Mild postischemic hypothermia limits cerebral injury following transient focal ischemia in rat neocortex
48. Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke
49. Tissue plasminogen activator reduces neurological damage after cerebral embolism
50. Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits
51. Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits
52. Tissue plasminogen activator for acute ischemic stroke
53. The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model
54. The effect of post-ischemic blood glucose levels on the density and distribution of ischemic brain damage in the rat
55. Postischemic insulin reduces spatial learning deficit following transient forebrain ischemia in the rat
56. Electrically elicited seizures from the inferior colliculus: A potential site for the genesis of epilepsy?
57. Postischemic seizures and necrotizing ischemic brain damage: Neuroprotective effect of postischemic diazepam and insulin
58. Insulin attenuates ischemic brain damage independent of its hypoglycemic effect
59. Intraventricular administration of insulin and IGF-1 in transient forebrain ischemia
60. Insulin reduction of cerebral infarction due to transient focal ischemia
61. Normoglycemia (not hypoglycemia) optimizes outcome from middle cerebral artery occlusion
62. Hyperbaric oxygen and cerebral infarction in the gerbil
63. Videodensitometric estimation of the protective effect of hyperbaric oxygen in the ischemic gerbil brain
64. Hyperbaric oxygen combined with nicardipine administration accelerates neurologic recovery after cerebral ischemia in a canine model
65. Hyperbaric oxygenation for arterial air embolism during cardiopulmonary bypass
66. Effect of hyperbaric oxygen therapy on survival after global cerebral ischemia in rats
67. Hyperbaric oxygen therapy in experimentally induced acute cerebral ischemia
68. Hyperbaric oxygen therapy accelerates neurologic recovery after 15-minute complete global cerebral ischemia in dogs
69. Results of hyperbaric oxygen therapy during temporary middle cerebral artery occlusion in unanesthetized cats
70. Oxygen poisoning in man
71. Oxygen poisoning in man
72. Reperfusion injury: Demonstration of brain damage produced by reperfusion after transient focal ischemia in rats
73. Hypoxia, hyperoxia, ischemia and brain necrosis
74. A pilot study of hyperbaric oxygen in the treatment of human stroke
75. Clinicopathological features of limb paralysis induced in rats by hyperbaric oxygen exposure
76. Central nervous system lesions in rats exposed to oxygen at high pressure
77. Ultrastructural pathology of hyperbaric oxygenation in the central nervous system, observations in the anterior horn gray matter
78. Pathogenesis of central nervous system lesions induced by exposure to hyperbaric oxygen
79. Hyperoxia produces neuronal necrosis in the rat
80. Effect of exposure to oxygen at 101 and 150 kPa on the cerebral circulation and oxygen supply in conscious rats
81. Hypotension: A major factor limiting recovery from cerebral ischemia
82. Effect of blood pressure and diabetes on stroke in progression
83. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension
84. Graded hypotension and MCA occlusion duration: Effect in transient focal ischemia
85. Pathophysiology of ischemic cell death: I. Time of onset of irreversible damage; importance of the different components of the ischemic insult
86. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats
87. Insulin protects brain tissue against focal ischemia in rats
88. Combination drug therapy and mild hypothermia: A promising treatment strategy for reversible, focal cerebral ischemia
89. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vivo
90. 2+] following human focal cerebral ischemia
91. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke
92. Postinjury magnesium treatment attenuates traumatic brain injury-induced cortical induction of p53 mRNA in rats